Consolidative High Dose Chemotherapy and Autologous Stem Cell Transplant for Patients with Primary Central Nervous System (CNS) Lymphoma or Non-Hodgkin Lymphoma with CNS Involvement Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen

Young Patricia A.; Gaut Daria; Kimaiyo Davis A.; Grotts Jonathan A.; Chute John P.; Schiller Gary J.; Timmerman John M.; de Vos Sven; Eradat Herbert A.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Consolidative High Dose Chemotherapy and Autologous Stem Cell Transplant for Patients with Primary Central Nervous System (CNS) Lymphoma or Non-Hodgkin Lymphoma with CNS Involvement Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen

【24h】

Consolidative High Dose Chemotherapy and Autologous Stem Cell Transplant for Patients with Primary Central Nervous System (CNS) Lymphoma or Non-Hodgkin Lymphoma with CNS Involvement Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen

机译：用于初中神经系统（CNS）淋巴瘤或非霍奇金淋巴瘤的患者的合并高剂量化疗和自体干细胞移植，CNS参与使用THIOTEPA，Busulfan和环磷酰胺调理方案

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共2页
作者
Young Patricia A.; Gaut Daria; Kimaiyo Davis A.; Grotts Jonathan A.; Chute John P.; Schiller Gary J.; Timmerman John M.; de Vos Sven; Eradat Herbert A.;
展开▼
作者单位

Univ Calif Los Angeles Los Angeles CA USA;

Univ Calif Los Angeles Los Angeles CA USA;

Univ Calif Los Angeles Los Angeles CA USA;

Univ Calif Los Angeles Los Angeles CA USA;

Univ Calif Los Angeles Dept Med Div Hematol Oncol Los Angeles CA 90024 USA;

Univ Calif Los Angeles Los Angeles CA USA;

Univ Calif Los Angeles Los Angeles CA USA;

Univ Calif Los Angeles Los Angeles CA USA;

Univ Calif Los Angeles Los Angeles CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. 用马利兰、环磷酰胺、足叶乙甙为预处理方案对急性髓系白血病患者异基因骨髓移植治疗第一次完全缓解时的高剂量化疗 [J] . 祁明芳, 郁知非中德临床肿瘤学杂志（英文版） . 2000,第001期
2. Consolidative High Dose Chemotherapy and Autologous Stem Cell Transplant for Patients with Primary Central Nervous System (CNS) Lymphoma or Non-Hodgkin Lymphoma with CNS Involvement Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen [J] . Young Patricia A., Gaut Daria, Kimaiyo Davis A., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：用于初中神经系统（CNS）淋巴瘤或非霍奇金淋巴瘤的患者的合并高剂量化疗和自体干细胞移植，CNS参与使用THIOTEPA，Busulfan和环磷酰胺调理方案
3. High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement [J] . David Qualls, Andrew Sullivan, Shuli Li, Clinical lymphoma, myeloma & leukemia . 2017,第12期

机译：高剂量Thiotepa，Busulfan，环磷酰胺和自体干细胞移植作为全身非霍奇金淋巴瘤的前期固结，同步中枢神经系统受累
4. Patients with Central Nervous System Lymphoma (CNSL) Undergoing Thiotepa, Busulfan, Cyclophosphamide-Conditioned Autologous Stem Cell Transplantation (TBC-ASCT) are at a Higher Risk for DNA Virus Infections Than Patients Receiving Traditional Conditioning [J] . Michael Scordo, Sejal M. Morjaria, Ankush Bhatia, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：None
5. Unusual Presentations of Central Nervous System Non-Hodgkin and Hodgkin Lymphoma: A Clinicopathologic Review of Four Tumours [C] . Lee HY, Chuah KL, Ng SB, International Congress of Neuropathology . 2010

机译：中枢神经系统非霍奇金和霍格金淋巴瘤的不寻常介绍：对四种肿瘤的临床病理综述
6. Correlates of fatigue in lymphoma patients undergoing autologous peripheral blood stem cell transplantation. [D] . El-Banna, Majeda Mohammed. 2004

机译：与进行自体外周血干细胞移植的淋巴瘤患者疲劳相关。
7. Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa Busulfan and Cyclophosphamide Conditioning Regimen [O] . Patricia A. Young, Daria Gaut, Davis K. Kimaiyo, -1

机译：大剂量化学疗法和自体干细胞移植后使用ThiotepaBusulfan和Cyclophosphamide调理方案在原发和继发中枢神经系统淋巴瘤中获得持久的生存结果
8. Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen [O] . Patricia A. Young, Daria Gaut, Davis K. Kimaiyo, 2020

机译：使用Thiotepa，Busulfan和环磷酰胺调理方案的高剂量化疗和自体干细胞移植后常等中枢神经系统淋巴瘤耐用的存活结果

Consolidative High Dose Chemotherapy and Autologous Stem Cell Transplant for Patients with Primary Central Nervous System (CNS) Lymphoma or Non-Hodgkin Lymphoma with CNS Involvement Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen

著录项

相似文献

相关主题

期刊订阅